Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin for prevention of preterm birth
IRCT20250203064629N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of aspirin in preterm birth (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Preterm labor. Started Feb 2025; status: completed.
02
Drugs
aspirin
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20250203064629N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250203064629N1.